Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body’s ...

In just 3 years, the Influenza Vaccines Research and Development (R&D) Roadmap Initiative has demonstrated important ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...

Researchers at the Perelman School of Medicine at the University of Pennsylvania have developed an experimental multivalent mRNA-based vaccine against all 20 known subtypes of influenza virus.

To develop more effective vaccines, a deeper understanding of influenza virus infection, as well as pathogenic and transmission mechanisms is required, with the ultimate goal of discovering of a ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Chaphalkar, Sushama R.. (2024, May 06). New influenza vaccine strategies aim to enhance protection ...

The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.

Researchers found that among 53,402 Cleveland Clinic employees in northern Ohio, getting the influenza vaccine was associated with a 27% increase in flu infections.